40 3 
Home Page  

  • SciELO

  • Google
  • SciELO
  • Google


Nutrición Hospitalaria

 ISSN 1699-5198 ISSN 0212-1611

BELLO-DURAN, Luis Alberto    VANEGAS-OTALVARO, Daniela. Variation in the level of the biocomponents immunoglobulin A and lactoferrin in human milk after Holder pasteurization. []. , 40, 3, pp.633-640.   23--2023. ISSN 1699-5198.  https://dx.doi.org/10.20960/nh.04218.

Background:

breast milk is the ideal food for newborns and infants, but there are factors that can prevent the practice of breastfeeding. Human milk banks (BLH) are a strategy to increase breastfeeding coverage; the donated milk is subjected to Holder pasteurization to guarantee its innocuousness, undergoing large changes in temperature and a decrease in the concentrations of biocomponents such as Immunoglobulin A (IgA) and lactoferrin (LF). This article describes the results of recent studies on the impact of Holder pasteurization on IgA and LF in human milk.

Material and methods:

a search for research articles related to the topic of interest was carried out in various databases and in accordance with inclusion criteria that considered the type of study, date of publication and quality of the journal.

Results:

the impact of Holder pasteurization on IgA and LF concentrations is not clear, given that the literature reports a variety of protocols and different results; however, the percentage reductions of both biocomponents are significant and consistent in the studies reviewed, suggesting the importance of establishing a standard protocol for their quantification.

Conclusions:

Holder pasteurization guarantees the microbiological quality of the milk distributed in HMB, but affects the amount of beneficial biocomponents for the final recipient. Government entities that regulate HMBs should evaluate the possibility of using other techniques that reduce the impact on biocomponents while preserving the microbiological quality of the product.

: Breastmilk; Milk banks; Biocomponents; Holder pasteurization; Immunoglobulin A; Lactoferrin.

        · |     · |     · ( pdf )